Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia

World Journal of Pediatrics

Volumn 5, Issue 3, 2009, Pages 216-221

  Pan, Li ^a   Fu, Jian Hua ^a   Xue, Xin Dong ^a   Xu, Wei ^a   Zhou, Ping ^b   Wei, Bing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidants; Bronchopulmonary dysplasia; Free radicals; Lung damage; Melatonin

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELATONIN; MYELOPEROXIDASE; NITRATE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ENZYME ACTIVITY; EVENING DOSAGE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HYPEROXIA; LUNG ALVEOLUS; LUNG DYSPLASIA; NONHUMAN; RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; CATALASE; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; HYPEROXIA; LUNG; LUNG INJURY; MALONDIALDEHYDE; MELATONIN; NITRATES; OXIDATIVE STRESS; PEROXIDASE; RATS; SUPEROXIDE DISMUTASE;

EID: 69249196022     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-009-0041-2     Document Type: Article

References (27)

1. Bhandari A, Bhandari V. Bronchopulmonary dysplasia: An update. Indian J Pediatr 2007;74:73-77.
2. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49.
3. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: Implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007;292: L1073-1084.
4. Asikainen TM, White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: Implications for antioxidant therapy. Antioxid Redox Signal 2004;6:155-167.
5. Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006;1757:573-589.
6. Gitto E, Reiter RJ, Sabatino G, Buonocore G, Romeo C, Gitto P, et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: Improvement with MT treatment. J Pineal Res 2005;39:287-293.
7. Warner BB, Stuart LA, Papes RA, Wispé JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998;275(1 Pt 1):L110-117.
8. Fu JH, Xue XD. Researches on lipid peroxidation of bronehoalveolar lavage and lung in premature rat with chronic lung disease. Zhong Guo You Sheng Yu Yi Chuan Za Zhi 2004;12:32-37. [In Chinese]
9. Veness-Meehan KA, Bottone FG Jr, Stiles AD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr Res 2000; 48:434-444.
10. Dani C, Cecchi A, Bertini G. Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr 2004;56:381-394.
11. Van Marter LJ. Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia. Biol Neonate 2006;89:303-312.
12. Nunes DM, Mota RM, Machado MO, Pereira ED, de Bruin VM, de Bruin PF. Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease. Braz J Med Biol Res 2008;41:926-931.
13. Pedreira PR, García-Prieto E, Parra D, Astudillo A, Diaz E, Taboada F, et al. Effects of melatonin in an experimental model of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L820-827.
14. Mollaoglu H, Topal T, Ozler M, Uysal B, Reiter RJ, Korkmaz A, et al. Antioxidant effects of melatonin in rats during chronic exposure to hyperbaric oxygen. J Pineal Res 2007;42:50-54.
15. Lee YD, Kim JY, Lee KH, Kwak YJ, Lee SK, Kim OS, et al. Melatonin attenuates lipopolysaccharide-induced acute lung inflammation in sleep-deprived mice. J Pineal Res 2009;46:53-57.
16. Welin AK, Svedin P, Lapatto R, Sultan B, Hagberg H, Gressens P, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007;61:153-158.
17. Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008;44:157-164.
18. Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki Z. Melatonin and its metabolites: New findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007;54:1-9.
19. Reiter RJ, Tan DX, Manchester LC, Lopez-Burillo S, Sainz RM, Mayo JC. Melatonin: Detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol 2003;527:539-548.
20. Al Qadi-Nassar B, Bichon-Laurent F, Portet K, Tramini P, Arnoux B, Michel A. Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice. Fundam Clin Pharmacol 2007;21:611-620.
21. Liao L, Ning Q, Li Y, Wang W, Wang A, Wei W, et al. CXCR2 blockade reduces radical formation in hyperoxia-exposed newborn rat lung. Pediatr Res 2006;60:299-303.
22. Kaarteenaho-Wiik R, Kinnula VL. Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J Histochem Cytochem 2004;52:1231-1240.
23. Mayo JC, Sainz RM, Antoli I, Herrera F, Martin V, Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002;59:706-713.
24. Sun HC, Qian XM, Nie SN, Wu XH. Serial analysis of gene expression in mice with lipopolysaccharide-induced acute lung injury. Chin J Traumatol 2005;8:67-73.
25. Todisco M. Effectiveness of a treatment based on melatonin in five patients with systemic sclerosis. Am J Ther 2006;13:84-87.
26. Pignone AM, Rosso AD, Fiori G, Matucci-Cerinic M, Becucci A, Tempestini A, et al. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. J Pineal Res 2006;41:95-100.
27. Jan JE, Wasdell MB, Freeman RD, Bax M. Evidence supporting the use of melatonin in short gestation infants. J Pineal Res 2007;42:22-27.